Merck KGaA announces new results for bifunctional immunotherapy M7824

22nd October 2018 Uncategorised 0

Includes data for head and neck cancer, biliary tract cancer and esophageal cancers

More: Merck KGaA announces new results for bifunctional immunotherapy M7824
Source: News